What Delta Medical Promotions AG does

Delta Medical Promotions AG (DMPAG), founded in 1999 and headquartered in Zurich, Switzerland, is a privately held pharmaceutical services platform that enables international healthcare manufacturers to register, distribute, and commercialize products across 13 emerging markets in Eastern Europe, the Caucasus, and Central Asia. The company operates as a one-stop alternative to a local affiliate for clients who want to enter commercially attractive but operationally demanding markets. Its service stack spans five interlocking revenue streams: pharmaceutical registration and regulatory affairs (436+ medicine/device approvals supported since 2000), medical affairs and pharmacovigilance, GDP-compliant distribution and logistics (>13,000 m2 warehousing, climate-controlled fleet, IoT-enabled cold chain, $>15M invested in infrastructure), commercialization and field promotion (300+ field specialists organized into Therapeutic Business Units), and market access/reimbursement support. Clients contract once with DMPAG in Zurich and settle in CHF, USD, or EUR, eliminating local CIS currency exposure.

The underlying technology combines regulatory workflows, an online partner portal with order tracking and real-time shipment visibility, machine-learning-assisted demand forecasting, and IoT-enabled cold-chain monitoring with Bluetooth data loggers and GPS tracking. Distribution is anchored by a direct-to-pharmacy model reaching 21,000+ pharmacies, 2,150+ hospitals and clinics, and 1,400+ cosmeceutical outlets across 12 markets, supplemented by Key Account Management with major pharmacy chains and emerging ePharmacy/3PL fulfillment. The customer base spans 50+ international manufacturing partners — including Gilead Sciences, LEO Pharma, Helsinn, Amgen, UPSA, Vitabiotics, URGO, and Mentholatum — across specialty pharma, biotech, medical devices, consumer health, and FSMP/nutraceutical segments. The company holds ISO 13485, ISO 22000, ISO 9001, GDP, and Swissmedic certifications, operates under an FCPA legal opinion with daily sanctions screening, and has been audited by 14 partners since 2021. Delta Medical is recognized as Top-6 in Ukraine by pharma sales (FY2025) and ranked #1 in medical representative visits and #2 across all pharmaceutical promotional channels in Ukraine in Q1 2026 per PromoTest data.

Name

Delta Medical Promotions AG

Legal name

Delta Medical Promotions AG

Website

https://deltaswiss.eu

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Delta Medical Promotions AG is a Swiss-headquartered pharmaceutical services platform that registers, distributes, and commercializes healthcare products for international manufacturers across 13 emerging markets in Eastern Europe, the Caucasus, and Central Asia.

Ownership category

akta.pro rank

Product category

Pharmaceutical Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industries

Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA), Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ)

Keywords

• Pharmaceutical registration services
• GDP-compliant distribution
• Medical affairs consulting
• Pharmacovigilance monitoring
• Contract sales organization

Headquarters

HQ city

Baar

HQ country

Switzerland

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Pharma Registration and Regulatory Affairs Services: Fees for regulatory affairs and market access services including dossier preparation, submission management, labeling localization across 14 regional languages, renewals, variations, and post-approval compliance. Since 2000, has supported 436+ medicine and device approvals.
2. Medical Affairs Services: Medical affairs service fees including scientific exchange, medical information inquiries, pharmacovigilance monitoring, aggregate safety reporting, risk management plan updates, early access programs, compassionate use, and named-patient supply programs.
3. Commercialization and Field Promotion Services: Sales force and marketing services organized by Therapeutic Business Units (TBUs) covering physician detailing, pharmacy promotions, medical science liaison engagements, Key Opinion Leader programs, product management, and consumer OTC marketing campaigns.
4. GDP-Compliant Distribution and Logistics Services: GDP-compliant distribution services including importation, customs clearance, warehousing (13,000+ m2), climate-controlled storage, refrigerated fleet delivery, and last-mile direct-to-pharmacy delivery across 12 markets. Over $15 million invested in GDP-certified facilities and delivery fleet.
5. Pharmacovigilance Services: Continuous safety monitoring, aggregate safety reporting, and risk-management-plan updates across the product lifecycle meeting local PV obligations in every market served.

Go-to-market motion4 records

Distribution channels5 records

Marketing channels7 records

Core offering

Delta Medical Promotions AG is a Swiss-governed pharmaceutical services company that helps international healthcare manufacturers register, launch, distribute, and promote their products across 13 emerging markets in Eastern Europe, the Caucasus, and Central Asia. The company delivers an integrated service portfolio covering pharmaceutical registration and regulatory affairs, medical affairs and pharmacovigilance, field promotion through 300+ specialists, and GDP-compliant climate-controlled distribution reaching 21,000+ pharmacies and 2,150+ hospitals and clinics. Clients contract once with DMPAG in Zurich and settle in CHF, USD, or EUR.

Product overview

Delta Medical Promotions AG operates as a pharmaceutical registration, distribution, and marketing services platform serving international healthcare manufacturers across 13 emerging markets in Eastern Europe, the Caucasus, and Central Asia. The company offers an integrated service portfolio encompassing: Pharmaceutical Registration Services (handling dossiers, labeling localization, renewals, and variations for 436+ approvals since 2000); GDP-Compliant Distribution (reaching 21,000+ pharmacies and 2,150+ hospitals/clinics with climate-controlled storage and real-time shipment tracking); Commercialization and Promotion (300+ field specialists across therapeutic business units including Oncology/Nephrology, ENT, Women's Health, Neurology, Pediatrics, and Rare Diseases); Medical Affairs Services (scientific exchange, KOL engagement, medical education programs); Pharmacovigilance Services (continuous safety monitoring and regulatory compliance); and Market Access Support (HTA submissions and pricing negotiations). The company acts as a contract sales organization and full-service commercial partner with flexible hybrid models.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Registration Services Registration management for pharmaceuticals, biologics, medical devices, FSMPs, supplements, disinfectants, and cosmetics across Eastern Europe, Caucasus, and Central Asia markets. Includes dossier preparation, submission management, labeling localization across 14 regional languages, renewals, variations, and post-approval compliance. For international healthcare manufacturers seeking market entry into 13 emerging markets.
• GDP-Compliant Distribution and Logistics Climate-controlled storage and temperature-monitored pharmaceutical distribution connecting manufacturers to 21,000+ pharmacies and 2,150+ hospitals and clinics across 12 markets. Includes importation, customs clearance, 13,000+ m2 of warehousing, refrigerated fleet delivery, and IoT-enabled cold-chain monitoring. For international pharmaceutical, medical device, and consumer health manufacturers needing compliant market access.
• Commercialization and Promotion Services 300+ field specialists in medical and pharmacy teams engaging physicians and pharmacists directly, supported by KOL programs, congress activity, and consumer campaigns for OTC and consumer health products. Includes brand management, disease-awareness programs, telemarketing, telesales, e-detailing, and digital demand generation. For international pharmaceutical, OTC, and consumer health manufacturers.
• Medical Affairs Services Scientific engagement, medical education, congress presence, clinical trial facilitation, MSL engagement, and KOL partnership cultivation across complex disease areas including genetics, immunology, nephrology, and oncology. Includes Center of Excellence formation and clinician society relationship development. For international pharmaceutical manufacturers requiring local scientific exchange support.
• Pharmacovigilance Services Continuous safety monitoring, aggregate safety reporting, risk management plan updates, and adverse event reporting across the product lifecycle, meeting local pharmacovigilance obligations in every market served. For pharmaceutical manufacturers requiring compliant safety surveillance across 13 emerging markets.
• Market Access and Reimbursement Positioning strategy, health-economic evidence development, HTA submissions, and pricing negotiations to support national and institutional formulary decisions. For pharmaceutical manufacturers needing reimbursement and formulary access across regional markets.

Quantifiable outcome

• 436+ medicine and device approvals supported since 2000
• +5 more outcomes

Named customers16 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• AmgencoreStrategic or Co-development PartnerBiomarker-guided therapy partnership for molecular diagnostic infrastructure supporting metastatic colorectal cancer treatment in Ukraine. Through a national testing network, Delta Medical and Amgen help oncology teams access extended RAS testing, a prerequisite for targeted therapy eligibility. Aligns Ukraine's oncology diagnostic capabilities with international standards.
• CSD LABcoreStrategic or Co-development PartnerMolecular diagnostic laboratory partnership supporting the Amgen biomarker-guided therapy collaboration. CSD LAB provides testing infrastructure for extended RAS testing for metastatic colorectal cancer patients in Ukraine.
• Gilead SciencescoreStrategic or Co-development PartnerStrategic partnership with Gilead Sciences for specialty pharmaceutical products in the CIS region. CIS Operations Director Sergey Piont meets regularly with Gilead's Regional Director to review progress and align on future collaboration plans.
• Galaxy PharmminorOthersGalaxy Pharm is a partner for international transportation of pharmaceutical cargo, providing reliable logistics services for Delta Medical's supply chain.
• MedizineminorOthersMedizine is an online store for vitamins and health products, partnering with Delta Medical to list portfolio products. Delta Medical's product portfolio can be viewed on the Medizine.ua platform.
• Mister BlisterminorOthersMister Blister is a news portal for medicine and pharmacy professionals, listed as a partner providing industry news coverage.

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Syneos Health: Global contract sales organization and commercialization services provider for pharma and biotech. Directly comparable to Delta Medical's 300+ field force, medical affairs, and full-service commercialization model, though operating at much larger scale and global footprint rather than focused on CIS/Central Asia.
• Indegene: Specialized commercial and medical services provider with strong emerging-markets presence. Comparable to Delta Medical in offering multi-channel HCP engagement, medical affairs, and emerging-markets commercialization for global pharma clients, with overlapping therapeutic business unit structure.
• PharmaLex (Cencora): Specialized regulatory affairs and pharmacovigilance services provider for pharma, now part of Cencora. Directly comparable to Delta Medical's regulatory affairs, market access, and pharmacovigilance service lines, particularly the dossier preparation, localization, and submission management workflows.
• FarmaMondo: Specialty pharmaceutical distributor focused on emerging markets and unlicensed/cancer medicines. Closely comparable to Delta Medical's specialty pharma and orphan drug distribution model in CIS/Central Asia, though operating with different geographic focus (Latin America, MEA).
• Crown Agents: International development company providing pharmaceutical supply chain, procurement, and distribution services in fragile and emerging markets. Comparable to Delta Medical's emerging-markets pharma distribution and government-tender experience, particularly in CIS-adjacent geographies.

Broad incumbents

• IQVIA: Largest global CRO and commercial services provider, encompassing contract sales, medical affairs, regulatory consulting, and distribution analytics. Overlaps with Delta Medical across the full service stack but operates at vastly larger scale and broader geographic coverage including emerging markets.
• ICON plc: Major global CRO providing clinical research, regulatory affairs, and commercialization services to pharma and biotech. Comparable to Delta Medical on the regulatory and medical affairs side of the value chain, with broader global reach but less specialty distribution depth.
• Zuellig Pharma: One of Asia's largest pharmaceutical distribution and services companies, covering importation, warehousing, distribution, and commercial services. Comparable to Delta Medical's GDP-compliant distribution and commercialization model, though serving Asia-Pacific rather than CIS/Central Asia.
• Movianto (PHOENIX Group): European pharmaceutical distribution specialist within PHOENIX Group, providing GDP-compliant warehousing and distribution. Comparable to Delta Medical's GDP-certified distribution infrastructure, IoT cold chain, and direct-to-pharmacy delivery model across European markets.
• Parexel International: Major global CRO providing clinical research, regulatory affairs, and biopharmaceutical services. Comparable to Delta Medical's regulatory affairs and medical affairs offerings, with greater global scale and clinical trial focus but less emerging-markets distribution depth.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/delta-medical

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Delta Medical Promotions AG